Pediatrics Articles

Pediatrics

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Donnithorne KJ et al. - To report on the efficacy of rituximab (RTX) therapy in standard treatment-refractory, chronic Henoch-Schonlein purpura, a retrospective chart review of 3 pediatric patients treated with RTX for severe refractory chronic Henoch-Schonlein purpura was performed. All 3 patients responded to 1 or 2 courses of RTX without serious adverse events.

Related Articles

Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura
International Journal of Hematology, 10/12/09    Relevance Score: 45%

A purpuric rash
Australian Family Physician, 11/09/09    Relevance Score: 44%

Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia
International Journal of Hematology, 10/13/09    Relevance Score: 43%

Immune thrombocytopenia associated with Mycoplasma pneumoniae infection: a case report and review of literature
Blood Coagulation & Fibrinolysis, 10/07/09    Relevance Score: 43%

Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura
Blood, 10/02/09    Relevance Score: 43%

Today in Pediatric Heme/Oncology...keeping you current

Nipple adenoma in infancy
Journal of Pediatric Surgery, 12/11/09

DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma
Cancer Chemotherapy and Pharmacology, 12/11/09

Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype
British Journal of Cancer, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address